Phillip Eric Lee
Net worth: 382 129 $ as of 30/06/2026
Net worth: 382 129 $ as of 30/06/2026
Phillip Eric Lee formerly worked at Cytokinetics, Inc., as Senior Director from 2015 to 2018, Adverum Biotechnologies, Inc., as Associate Director from 2015 to 2016, 4D Molecular Therapeutics, Inc., as Senior Director & Vice President from 2018 to 2021, Vaxart, Inc., as Chief Financial & Accounting Officer from 2022 to 2025, Centerview Partners LLC, as Principal from 2009 to 2015, and Clover Biopharmaceuticals Ltd., as Chief Financial & Business Development Officer.
Mr. Lee received his undergraduate degree from the University of California, Berkeley.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
VAXART, INC. 0.26% | 24/03/2025 | 631,619 ( 0.26% ) | 382 129 $ | 30/06/2026 |
| Companies | Position | End |
|---|---|---|
| VAXART, INC. | Director of Finance/CFO | 19/05/2025 |
| CLOVER BIOPHARMACEUTICALS, LTD. | Director of Finance/CFO | 01/07/2022 |
| 4D MOLECULAR THERAPEUTICS, INC. | Director/Board Member | 01/01/2021 |
| CYTOKINETICS, INCORPORATED | Director/Board Member | 01/03/2018 |
| ADVERUM BIOTECHNOLOGIES, INC. | Corporate Officer/Principal | 01/01/2016 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 7 |
|---|---|
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
University of California, Berkeley
University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centerview Partners LLC
Centerview Partners LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells novel gene therapies | Health Technology |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Vaxart, Inc.
Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Select your edition
All financial news and data tailored to specific country editions